tissue engineering Latest News

Explosive growth in the field of tissue engineering and regenerative medicine has led to innovative and promising applications and techniques, many of which are now being tested in human clinical...

Stem cells can be grown on biocompatible scaffolds to form complex tissues such as bone, cartilage, and muscle for repair and regeneration of damaged or diseased tissue.

New, advanced techniques are needed that can mimic the normal blood supply that feeds natural bone to improve the viability and success of restorative procedures to replace damaged or diseased bone tissue using engineered constructs.

Filling the need for a lab textbook in this rapidly growing field, A Laboratory Course in Tissue Engineering helps students develop hands-on experience.

More than half (52%) of the companies comprising the tissue engineering (TE) and stem cell industries are revenue-generating, compared to about 21% four years ago, reports Genetic Engineering & Biotechnology News (GEN).

The inaugural issue of BioResearch Open Access, a new bimonthly peer-reviewed open access journal, was released today by Mary Ann Liebert, Inc., publishers.

Three-dimensional clusters of pancreatic beta-cells that live much longer and secrete more insulin than single cells grown in the laboratory are valuable new tools for studying pancreatic diseases such as diabetes and for testing novel therapies.

A novel method for printing human cells onto surfaces in defined patterns can help advance research on tissue engineering and regeneration, as described in an article in Tissue Engineering, Part C, Methods, a journal from Mary Ann Liebert, Inc.

The biological scaffold that gives structure to a heart valve after its cellular material has been removed can be freeze-dried and stored for later use as a tissue-engineered replacement valve to treat a failing heart

When: November 17-18, 2011 Where: Omni Parker House - Boston, MA

3 hour course to be held in Boston on November 17 lead by David Kaplan, Ph.D., Tufts University; Melik Demirel, Ph.D., Pennsylvania University; Derek J. Hansford, Ph.D., Ohio State University; and Umut A. Gurkan, Ph.D., Harvard-MIT.

This year’s theme is about moving into the third dimension of drug discovery and development. This conference will take place on November 17-18, 2011 in Boston, MA. Early registration discounts will be offered until August 26.

A conference, sponsored by RNID – Action on Hearing Loss , will see eminent clinicians and scientists from around the world discuss and debate how tissue engineering in the auditory system could transform the lives of deaf people.

Overcoming the current technological and regulatory barriers to the development of this exciting branch of modern medicine will be discussed by leading academics working in regenerative medicine and cell biology

The first successful report of using cell-depleted lung as a natural growth matrix for generating new rat lung from embryonic stem cells is presented in a breakthrough article in the peer-reviewed journal, Tissue Engineering, Part A

Cell therapy has generated a great deal of headlines. Meanwhile, tissue engineering has generated a great deal of revenue.

Treatments via cell therapy and tissue engineering constitute a $6.9 billion worldwide market as they have become a major thrust of new clinical practices in nearly all major medical specialties, according to a new MedMarket Diligence report.

Machine that prints body tissues coming to market thanks to Foundation investment

A new MedMarket Diligence report on “Tissue Engineering and Cell Therapy Worldwide” details the success in technology development and clinical practice for products in use across a spectrum of clinical areas in the global market.

Clinical testing of novel therapies of advances in tissue engineering and regenerative medicine will one day enable the replacement of diseased or damaged human muscle, bone, tendons, and ligaments depends on the availability of good animal models.

With over 150 active companies developing and market products for cell therapy and tissue engineering applications, the industry is rapidly growing. Increasingly complex cell, tissue and organ systems are being repaired, restored or even replaced.

GTCbio’s 5th Annual Modern Drug Discovery & Development Conference (to be held October 14-16, 2009 in San Diego, CA) has an important focus on Stem Cell Discovery & Development.

Leaders in the field were asked what critical steps are needed for tissue engineering to achieve broad critical success by 2021 and the findings were published in the December 2007 issue of Tissue Engineering, published by Mary Ann Liebert, Inc.

Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report which finds that the worldwide burn treatment market has experienced growth of 7.6% from 2001 to 2006, reaching $1.9 billion.